Cargando…

A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer

Prostate cancer (PCa) is the second most common malignancy in men, but its exact pathogenetic mechanisms remain unclear. This study explores the effect of enhancer RNAs (eRNAs) in PCa. Firstly, we screened eRNAs and eRNA -driven genes from The Cancer Genome Atlas (TCGA) database, which are related t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Shuaishuai, Wang, Zheng, Zhao, Li, Zhao, ChenHui, Yuan, DaJiang, Wang, Jingqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276043/ https://www.ncbi.nlm.nih.gov/pubmed/34267780 http://dx.doi.org/10.3389/fgene.2021.676845

Ejemplares similares

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma
por: Gao, Liuying, et al.
Publicado: (2022)

eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer
por: Zhang, Xiaona, et al.
Publicado: (2020)

Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment
por: Ding, Mengting, et al.
Publicado: (2018)

Exploring the potential of eRNAs in cancer immunotherapy
por: Luo, Lianxiang, et al.
Publicado: (2022)

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer
por: Zhao, Jingwen, et al.
Publicado: (2016)

Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme
por: Guo, Xiao-Yu, et al.
Publicado: (2021)

Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
por: Napoli, Sara, et al.
Publicado: (2022)

Enhancer RNA (eRNA) in Human Diseases
por: Wang, Yunzhe, et al.
Publicado: (2022)

Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
por: Zhang, Zhao, et al.
Publicado: (2019)

Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer
por: Wang, Bofang, et al.
Publicado: (2022)

Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets
por: Bing, Zhitong, et al.
Publicado: (2019)

Identification of Key eRNAs for Spinal Cord Injury by Integrated Multinomial Bioinformatics Analysis
por: Huang, Runzhi, et al.
Publicado: (2021)

eRNAs Identify Immune Microenvironment Patterns and Provide a Novel Prognostic Tool in Acute Myeloid Leukemia
por: Jiang, Ziming, et al.
Publicado: (2022)

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer
por: Ma, Hangbin, et al.
Publicado: (2023)

Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Novel Prognostic Signature for Acute Myeloid Leukemia: Bioinformatics Analysis of Combined CNV-Driven and Ferroptosis-Related Genes
por: Han, Chunjiao, et al.
Publicado: (2022)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
por: Na, Zhijing, et al.
Publicado: (2021)

A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas
por: Zhu, HuaXin, et al.
Publicado: (2022)

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma
por: Wu, Pu, et al.
Publicado: (2022)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
por: Qu, Ying, et al.
Publicado: (2020)

Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence
por: Fu, Min, et al.
Publicado: (2021)

Comprehensive transcriptomic analysis of immune-related eRNAs associated with prognosis and immune microenvironment in melanoma
por: Gan, Yuling, et al.
Publicado: (2022)

Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma
por: Wang, Pei, et al.
Publicado: (2020)

Chromatin looping and eRNA transcription precede the transcriptional activation of gene in the β-globin locus
por: Kim, Yea Woon, et al.
Publicado: (2015)

Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer
por: Song, Guoda, et al.
Publicado: (2022)

DeepITEH: a deep learning framework for identifying tissue-specific eRNAs from the human genome
por: Zhang, Tianjiao, et al.
Publicado: (2023)

A Robust Seven-Gene Signature Associated With Tumor Microenvironment to Predict Survival Outcomes of Patients With Stage III–IV Lung Adenocarcinoma
por: Zhao, Hao, et al.
Publicado: (2021)

A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas
por: Ren, Peng, et al.
Publicado: (2022)

Transcriptome Analysis Identifies Piwi-Interacting RNAs as Prognostic Markers for Recurrence of Prostate Cancer
por: Zuo, Yuanli, et al.
Publicado: (2019)

Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance
por: Hu, Xin, et al.
Publicado: (2022)

Integrative Analysis of MicroRNA and Gene Interactions for Revealing Candidate Signatures in Prostate Cancer
por: Wei, Jingchao, et al.
Publicado: (2020)

Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma
por: Lv, Liting, et al.
Publicado: (2020)

A novel lysosome-related gene signature coupled with gleason score for prognosis prediction in prostate cancer
por: Huang, Ying, et al.
Publicado: (2023)

Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas
por: Tan, Shichuan, et al.
Publicado: (2022)

Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining
por: Liu, Kun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3u8j9g2llc574nbl8fhl0ln22t